NCT06380777

Establishment and Application of Digital Diagnosis and Treatment System for Sarcopenia

Establishment and Application of a Digital Diagnosis and Treatment System for Sarcopenia
Peking Union Medical College Hospital·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Sarcopenia
Study type
Observational
Sponsor & location
Primary sponsor
Peking Union Medical College Hospital
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2023
End date
Dec 31, 2028
Enrollment
10000 participants
Primary outcome

Appendicular skeletal muscle mass index

Summary

The goal of this observational study is to establish a digital diagnosis and treatment system
 for sarcopenia, integrating research outcomes into a unified approach encompassing a digital
 vaccine (early warning screening model), digital drug (intervention model associated with
 pathogenesis), and digital rehabilitation (preventive system combining early warning and
 treatment). This aims to create a digital visual tertiary prevention network for sarcopenia.
 
 Research aims:
 
 Evaluate the effectiveness of the digital vaccine through a cross-sectional epidemiological
 survey.
 
 Establish a specialized cohort for sarcopenia through a longitudinal investigation,
 implementing the digital drug and digital rehabilitation interventions.
 
 Participants will:
 
 Engage in screening and assessment based on inclusion and exclusion criteria.
 
 Be monitored longitudinally, with tailored interventions for those with muscle atrophy and
 regular follow-ups for at-risk individuals.
 
 Key outcomes will focus on sarcopenia indicators, serum biomarkers, and clinical endpoints
 such as fracture rates, weakness classification, and quality of life.

ICD-10 classifications
Kaposi sarcomaHerniaTaeniasisTaenia saginata taeniasisDiaphragmatic hernia
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06380777
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06380777 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking Union Medical College Hospital and is currently Recruiting. The study focuses on Sarcopenia. Target enrollment is 10000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.